Skip to content
Parakho

Krsnaa Diagnostics Ltd

NSE KRSNAABSE 543328

Q1 FY27, unaudited

Revenue
₹210.66 Cr
Profit after tax
₹15.82 Cr

As filed with the exchange, standalone basis.

Statement of profit and loss

Figures in ₹ crore, reproduced from the results data files the company filed with NSE under Regulation 33 of the SEBI (LODR) Regulations. Nothing is restated, adjusted or estimated.

Statement of profit and loss, standalone basis
₹ croreQ1 FY27vs a year agoFY26
Revenue from operations210.66+19.96%690.95
Other income7.21+80.32%43.41
Total income217.87+21.30%734.36
Employee benefit expense28.45+0.15%109.55
Finance costs14.72+135.69%33.94
Depreciation & amortisation27.70+28.78%89.76
Total expenses196.35+28.10%602.04
Profit before tax21.52−18.31%132.32
Tax expense5.70−15.93%29.65
Profit after tax15.82−19.13%102.68
Total comprehensive income15.81−19.58%102.63
Earnings per share
Earnings per share, basic₹4.88₹31.69
Earnings per share, diluted₹4.81₹31.26

Q1 FY27 — unaudited, from the company’s filing with NSE. Source

Q1 FY26, the year-ago base — unaudited, from the company’s filing with NSE. Source

FY26 — from the company’s filing with NSE. Source

Earnings call

Q4 FY26

Krsnaa Diagnostics reported FY26 revenue of approximately INR7,728 million with EBITDA margin of around 28% and reported PAT of approximately INR1,014 million, crossing INR1,000 million in PAT for the first time. Management said Q4 revenue grew about 4% year-on-year with EBITDA margin of 29%, while DSO improved from 155 days to 139 days during the quarter. Management outlined plans for Rajasthan ramp-up, retail scale-up, and further capital investment of INR5,000 million in FY27.

Generated by AI from the filed transcript; every statement on the full page carries its verbatim quote. Read the cited summary

Filings

12 shown · 44 published by the exchange

BSE corporate announcements, classified by Parakho. The exchange’s own category is kept alongside our classification so a reclassification never rewrites history.

Page generated from filings held to 20 Aug 2026.